Send feedback

EIF3F p.Phe232Val

c.694T>G · rs141976414 · VCV617475

Pathogenic/Likely pathogenic Multiple submitters
Classification
Pathogenic/Likely pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 36 submitters
AlphaMissense
likely pathogenic
0.9997 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.157%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
4
neurodevelopmental disorder

Computational evidence

Protein change
AlphaMissense0.9997likely pathogenic ✓ concordant with ClinVar · top 6% in EIF3F
REVEL0.759pathogenic-leaning
SaProtLLR -12.47damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.8GERP 0.76, phastCons 1
Regional constrainto/e 0.75unconstrained · MANE · 8,406 bp · p 4.6e-06 · regional, not allelic
Overall
CADD28.9PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.157% European (non-Finnish) · 1,854/1,179,998 alleles
Filtering AF 0.151% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.149%
Overall 0.125% 2,020/1,614,072 alleles · rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.182% 548
European (non-Finnish)grpmax 0.157% 636
Remaining individualsnot grpmax-eligible 0.107% 933
Admixed American 0.0367% 2,728
African / African-American 0.0227% 4,414
South Asian 0.00439% 22,762
Finnishnot grpmax-eligible 0.00312% 32,014

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EIF3F
Protein
p.Phe232Val
Coding
c.694T>G
MANE Select
NM_003754
dbSNP
rs141976414
Type
single nucleotide variant
Location
chr11:7994466 (GRCh38)
Gene constraint
LOEUF 0.46 · pLI 0.99 (gnomAD)
Structure
AlphaFold pLDDT 75.97 · 29 PDB
Residue 232
a UniProt-annotated variant site (in mrt67; decreased protein abundance); a β-strand
Full EIF3F gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/eif3f-p-phe232val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown